METHODS	A backward-elimination approach evaluated potential predictors ( baseline estimated glomerular filtration rate and left-ventricular mass index ; age at first dose ; baseline and change from baseline at 12 months of globotriaosylceramide ( urine , plasma ) ; urine protein excretion ; and systolic and diastolic blood pressure ) .\